Impact of fluticasone diskhaler on health-related quality of life in asthmatic patients

Tokai Journal of Experimental and Clinical Medicine

Volumn 27, Issue 3, 2002, Pages 79-84

  Kondo, Tetsuri ^a   Tanigaki, Toshimori ^a   Ono, Yoshiaki ^a   Tazaki, Gen ^a   Urano, Tetsuya ^a   Tajiri, Sakurako ^a   Eguchi, Kenji ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchial asthma; Health related quality of life; Hyland's living with asthma questionnaire

Indexed keywords

BECLOMETASONE; FLUTICASONE; FLUTICASONE PROPIONATE; STEROID;

ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; METERED DOSE INHALER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STEROID THERAPY; TREATMENT OUTCOME;

ADULT; AGED; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; BRONCHODILATOR AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0036769901     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Barnes N: Relative safety and efficacy of inhaled corticosteroids. J All Clin Immunol 101: S460-464, 1998.
2. Kondo T, Wakita K, Hayashi Y, et al: Inhaled flow and handling of Fluticasone Diskhaler by asthmatic patients. Tokai J Med 25: 79-85, 2000.
3. Mahajan P, Okamoto LJ, Schaberg A, et al: Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma. J Asthma 34: 227-234, 1997.
4. Matsumoto K, Hashimoto K, Satoh J, et al: A questionnaire study on QOL and local untoward effects in the patients switched from BDP to FP. Jpn J Allergol 49 (2,3): 234, 2000 (in Japanese).
5. Taniguchi H, Kondo H, Mikawa K, et al: Effect of switching form BDP to FP in severe asthmatic patients. Jpn J Allergol 49 (2,3): 235, 2000 (in Japanese).
6. Kondo T, Tanigaki T, Ono Y, Tazaki G, Urano T, et al. Acceptability of Hyland's living with asthma questionnaire for Japanese asthmatic patients. Int Med 39: 798-803, 2000.
7. Hyland ME, Finnis S, Irvine SH: A scale for assessing quality of life in adult asthma suffers. J Psychosom Res 35: 99-110, 1991.
8. Hyland ME, Kenyon CAP, Jacobs PA: Sensitivity of quality of life domains and constructs to longitudinal change in a clinical trial comparing slameterol with placebo in asthmatics. Qual Life Res 3: 121-126, 1994.
9. Hyland ME, Bellesis M, Thompson PJ, et al: The construct of asthma quality of life: psychometric, experimental and correlational evidence. Psycol and Health 12: 101-121, 1996.
10. Fabbri L, Burge PS, Croonenbourgh L: Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma for one year. Thorax 48: 817-823, 1993.
11. Pauwels RA, Yernault JC, Demedts MG, et al: Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Am J Respir Crit Care Med 157: 827-832, 1998.
12. Greening AP, Ind PW, Northfield M, et al: Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 344: 219-224, 1994.
13. Tsukino M, Nishimura K, Hajiro T, et al: Effect of treatment of health related quality of life in patients with asthma. Jpn J Respir Dis 36: 41-45, 1998 (in Japanese, Abstract in English).
14. Van der Molen T, Sears MR, de Graaff CS, et al: Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Eur Respir J 12: 30-34, 1998.
15. Shieh WB: Preference for the Diskhaler rather than the metered dose inhaler inpatietns with airway obstruction. Chang Gung Med J 17: 20-27, 1994.
16. Apter AJ, Reisine ST, Affleck G, et al: Adherence with twice-daily dosing of inhaled steroids. Am J Respir Crit Care Med 157: 1810-1817, 1998.